PTS Risk, VTE Prevention, And CVI Inflammation Research Update
Post-Thrombotic Syndrome: Risk And Prevention
Risk factors include obesity, prior venous disease, residual thrombosis, and persistent inflammation, with models adding Villalta score and employment status. Anticoagulation duration alone does not reduce risk, but avoiding recurrence matters. Early mobilization combined with compression, rather than compression alone, appears to lower both overall and severe post-thrombotic syndrome rates, while a large statin trial found no benefit.
Comparing American And European Venous Guidelines
Both societies agree duplex ultrasound is the diagnostic test of choice and endovenous ablation is preferred over surgical stripping. Differences emerge in telangiectasia workup, compression recommendations, and superficial vein thrombosis management, reflecting differing healthcare systems and regulatory pathways rather than differing evidence.
Combined Prophylaxis And Inflammation Research
A Cochrane review found combining pharmacologic prophylaxis with intermittent pneumatic compression reduces pulmonary embolism and deep vein thrombosis beyond either modality alone, though bleeding risk rises. Separate research links T-helper cell cytokine networks to chronic venous insufficiency, suggesting existing drugs as a possible treatment avenue.
